Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose TTS-Fentanyl D-TRANS in Taiwan Patients With Cancer Pain
NCT00771199Phase 4Completed
- Sponsor
- Janssen-Cilag
- Start
- Oct 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fentanyl (transdermal patch + oral transmucosal lozenge) in cancer pain, sponsored by Janssen-Cilag. Primary endpoint: Percentage of Participants Dropped From Study due to Adverse Events. Started Oct 2008; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00771199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771199.